当前位置: X-MOL 学术Ann. N. Y. Acad. Sci. › 论文详情
Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
Annals of the New York Academy of Sciences ( IF 4.728 ) Pub Date : 2020-10-16 , DOI: 10.1111/nyas.14508
Xue‐Feng Leng; Hiroyuki Daiko; Yong‐Tao Han; You‐Sheng Mao

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide, especially in East Asia. ESCC accounts for more than 90% of esophageal cancer. Currently, neoadjuvant therapy in combination with surgical resection is the mainstay of treatment. However, the overall survival rate of patients with locally advanced ESCC is not satisfactory even when treated following the standard treatment guidelines. With neoadjuvant chemoradiotherapy, chemotherapy, or emerging immunotherapy, continuous exploration of efficacy in relation to ESCC is expected to improve overall survival further. Here, we review and summarize current evidence for efficacy of preoperative therapy for locally advanced ESCC.
更新日期:2020-10-17

 

全部期刊列表>>
Springer 纳米技术权威期刊征稿
全球视野覆盖
施普林格·自然新
chemistry
3分钟学术视频演讲大赛
物理学研究前沿热点精选期刊推荐
自然职位线上招聘会
欢迎报名注册2020量子在线大会
化学领域亟待解决的问题
材料学研究精选新
GIANT
ACS ES&T Engineering
ACS ES&T Water
屿渡论文,编辑服务
ACS Publications填问卷
阿拉丁试剂right
麻省大学
西北大学
湖南大学
华东师范大学
王要兵
浙江大学
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
天合科研
x-mol收录
陆军军医大学
李霄鹏
廖矿标
试剂库存
down
wechat
bug